Growth Metrics

Haemonetics (HAE) Divestments (2017 - 2024)

Haemonetics' quarterly Divestments came in at $1.5 million in Q1 2024, down 85.9% quarter-over-quarter from $10.6 million in Q1 2022.

Haemonetics has reported Divestments for 5 years, with the latest figure at $1.5 million in Q1 2024.

  • For the quarter ending Q1 2024, Divestments changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2024 stood at $1.5 million (down 85.9% YoY), and the FY2025 full-year result was $43.3 million, up 2786.07% from the prior year.
  • Divestments for Q1 2024 stood at $1.5 million, down from $10.6 million in the prior quarter.
  • The five-year high for Divestments was $45.0 million in Q3 2020, with the low at -$391000.0 in Q4 2020.
  • Average Divestments over 3 years is $14.2 million, with a median of $6.1 million recorded in 2022.
  • Peak annual rise in Divestments reached 2821.74% in 2022, while the deepest fall reached 2821.74% in 2022.
  • Tracing HAE's Divestments over 3 years: stood at -$391000.0 in 2020, then surged by 2821.74% to $10.6 million in 2022, then sank by 85.9% to $1.5 million in 2024.
  • The last three Divestments figures came in at $1.5 million (Q1 2024), $10.6 million (Q1 2022), and -$391000.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Haemonetics 3.18 Bn 2.93 Bn 198.21 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 30, 2024 1.50 Mn
Jan 1, 2022 10.64 Mn
Dec 26, 2020 -391,000.00
Sep 26, 2020 44.98 Mn
Jun 29, 2019 9.81 Mn
Jul 1, 2017 9.00 Mn